🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Maryland › Baltimore

Etid klinik pou Ensifizyans kadyak nan Baltimore, MD

24 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06424288

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Johns Hopkins University, Baltimore
Laj 30 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06517186

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Ap rekriteFaz 3
  • Research Site, Baltimore
  • Research Site, Annapolis · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Ap rekriteFaz 3
  • University of Maryland Medical Center, Baltimore
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
  • Johns Hopkins University, Baltimore
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Baltimore
  • Research Site, Lutherville-Timonium · 10 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • Baltimore, MD Investigative Site 10101, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • University of Maryland Medical Center, Baltimore
  • The Johns Hopkins Hospital, Baltimore
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Ap rekriteFaz 2
  • Local Institution - 106, Baltimore
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814

Rilonacept in Subjects With Cardiac Sarcoidosis

Ap rekriteFaz 2
  • Johns Hopkins University, Baltimore
Laj 18 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT06660732

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Ca, Baltimore
  • Mercy Medical Center, GI Research, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

Ap rekrite
  • Johns Hopkins Medical Institution, Baltimore
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

Ap rekrite
  • Johns Hopkins Center for Health Equity, Baltimore
Laj 30 a 70 · Tout sèks · Mizajou Jul 15, 2026 · NCT06364644

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • MedStar, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Ap rekriteFaz 2
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 18 a 79 · Tout sèks · Mizajou May 27, 2026 · NCT06991257

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Ap rekrite
  • Johns Hopkins, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152

Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Johns Hopkins Medical Institutions, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Mar 9, 2026 · NCT00181259

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Ap rekriteEtid obsèvasyon
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06932081

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

Ap rekriteEtid obsèvasyon
  • University of Maryland Medical Center, Baltimore
  • Johns Hopkins University School of Medicine, Baltimore
Laj 18 a 85 · Tout sèks · Mizajou Jan 20, 2026 · NCT00733590

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure

Ap rekriteEtid obsèvasyon
  • Johns Hopkins Hospital, Baltimore
Laj 18 a 90 · Tout sèks · Mizajou Jan 12, 2026 · NCT06299436

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Ap rekriteFaz 1
  • Johns Hopkins University, Baltimore
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.